Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes : a literature review

Detalhes bibliográficos
Autor(a) principal: Frankenberg, Anize Delfino von
Data de Publicação: 2017
Outros Autores: Reis, André Fernandes, Gerchman, Fernando
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/206429
Resumo: Elevated hepatic glucose production, impaired insulin secretion, and insulin resistance – abnormalities of glucose metabolism typically found in subjects with obesity – are major factors underlying the pathogenesis of type 2 diabetes (DM2) and the metabolic syndrome (MS). Adiponectin is a major regulator of glucose and lipid homeostasis via its insulin-sensitizing properties, and lower levels seems to be associated with the development of DM2 and MS. The purpose of this review is to clarify the mechanisms whereby adiponectin relates to the development of DM2 and MS and the association between polymorphisms of the adiponectin gene, circulating levels of the hormone, and its relationships with DM2. In addition, the impact of dietary lipids in the circulating levels of adiponectin will be addressed. According to the literature, circulating adiponectin levels seem to decrease as the number of MS components increases. Lower adiponectin concentrations are associated with higher intra-abdominal fat content. Therefore, adiponectin could link intra-abdominal fat with insulin resistance and development of MS. Therapeutic strategies that target the MS and its components, such as lifestyle modification through physical activity and weight loss, have been shown to increase adiponectin concentrations. Possible roles of diets containing either low or high amounts of fat, or different types of fat, have been analyzed in several studies, with heterogeneous results. Supplementation with n-3 PUFA modestly increases adiponectin levels, whereas conjugated linoleic acid supplementation appears to reduce concentrations when compared with unsaturated fatty acid supplementation used as an active placebo
id UFRGS-2_bf2381af232dba126156eb4b7841f1d7
oai_identifier_str oai:www.lume.ufrgs.br:10183/206429
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Frankenberg, Anize Delfino vonReis, André FernandesGerchman, Fernando2020-03-04T04:20:21Z20172359-4292http://hdl.handle.net/10183/206429001110514Elevated hepatic glucose production, impaired insulin secretion, and insulin resistance – abnormalities of glucose metabolism typically found in subjects with obesity – are major factors underlying the pathogenesis of type 2 diabetes (DM2) and the metabolic syndrome (MS). Adiponectin is a major regulator of glucose and lipid homeostasis via its insulin-sensitizing properties, and lower levels seems to be associated with the development of DM2 and MS. The purpose of this review is to clarify the mechanisms whereby adiponectin relates to the development of DM2 and MS and the association between polymorphisms of the adiponectin gene, circulating levels of the hormone, and its relationships with DM2. In addition, the impact of dietary lipids in the circulating levels of adiponectin will be addressed. According to the literature, circulating adiponectin levels seem to decrease as the number of MS components increases. Lower adiponectin concentrations are associated with higher intra-abdominal fat content. Therefore, adiponectin could link intra-abdominal fat with insulin resistance and development of MS. Therapeutic strategies that target the MS and its components, such as lifestyle modification through physical activity and weight loss, have been shown to increase adiponectin concentrations. Possible roles of diets containing either low or high amounts of fat, or different types of fat, have been analyzed in several studies, with heterogeneous results. Supplementation with n-3 PUFA modestly increases adiponectin levels, whereas conjugated linoleic acid supplementation appears to reduce concentrations when compared with unsaturated fatty acid supplementation used as an active placeboapplication/pdfengArchives of endocrinology and metabolism. São Paulo, SP. Vol. 61, n. 6 (2017), p. 614-622Diabetes mellitus tipo 2AdiponectinaSíndrome metabólicaRevisãoAdiponectinMetabolic syndromeType 2 diabetesRelationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes : a literature reviewinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001110514.pdf.txt001110514.pdf.txtExtracted Texttext/plain45361http://www.lume.ufrgs.br/bitstream/10183/206429/2/001110514.pdf.txtd7447edaa52c00c7ab0058b847b0a458MD52ORIGINAL001110514.pdfTexto completo (inglês)application/pdf409496http://www.lume.ufrgs.br/bitstream/10183/206429/1/001110514.pdf905f5ec0b9c00f7c4eed7cb5adc694f6MD5110183/2064292020-03-05 04:18:06.293604oai:www.lume.ufrgs.br:10183/206429Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2020-03-05T07:18:06Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes : a literature review
title Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes : a literature review
spellingShingle Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes : a literature review
Frankenberg, Anize Delfino von
Diabetes mellitus tipo 2
Adiponectina
Síndrome metabólica
Revisão
Adiponectin
Metabolic syndrome
Type 2 diabetes
title_short Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes : a literature review
title_full Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes : a literature review
title_fullStr Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes : a literature review
title_full_unstemmed Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes : a literature review
title_sort Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes : a literature review
author Frankenberg, Anize Delfino von
author_facet Frankenberg, Anize Delfino von
Reis, André Fernandes
Gerchman, Fernando
author_role author
author2 Reis, André Fernandes
Gerchman, Fernando
author2_role author
author
dc.contributor.author.fl_str_mv Frankenberg, Anize Delfino von
Reis, André Fernandes
Gerchman, Fernando
dc.subject.por.fl_str_mv Diabetes mellitus tipo 2
Adiponectina
Síndrome metabólica
Revisão
topic Diabetes mellitus tipo 2
Adiponectina
Síndrome metabólica
Revisão
Adiponectin
Metabolic syndrome
Type 2 diabetes
dc.subject.eng.fl_str_mv Adiponectin
Metabolic syndrome
Type 2 diabetes
description Elevated hepatic glucose production, impaired insulin secretion, and insulin resistance – abnormalities of glucose metabolism typically found in subjects with obesity – are major factors underlying the pathogenesis of type 2 diabetes (DM2) and the metabolic syndrome (MS). Adiponectin is a major regulator of glucose and lipid homeostasis via its insulin-sensitizing properties, and lower levels seems to be associated with the development of DM2 and MS. The purpose of this review is to clarify the mechanisms whereby adiponectin relates to the development of DM2 and MS and the association between polymorphisms of the adiponectin gene, circulating levels of the hormone, and its relationships with DM2. In addition, the impact of dietary lipids in the circulating levels of adiponectin will be addressed. According to the literature, circulating adiponectin levels seem to decrease as the number of MS components increases. Lower adiponectin concentrations are associated with higher intra-abdominal fat content. Therefore, adiponectin could link intra-abdominal fat with insulin resistance and development of MS. Therapeutic strategies that target the MS and its components, such as lifestyle modification through physical activity and weight loss, have been shown to increase adiponectin concentrations. Possible roles of diets containing either low or high amounts of fat, or different types of fat, have been analyzed in several studies, with heterogeneous results. Supplementation with n-3 PUFA modestly increases adiponectin levels, whereas conjugated linoleic acid supplementation appears to reduce concentrations when compared with unsaturated fatty acid supplementation used as an active placebo
publishDate 2017
dc.date.issued.fl_str_mv 2017
dc.date.accessioned.fl_str_mv 2020-03-04T04:20:21Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/other
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/206429
dc.identifier.issn.pt_BR.fl_str_mv 2359-4292
dc.identifier.nrb.pt_BR.fl_str_mv 001110514
identifier_str_mv 2359-4292
001110514
url http://hdl.handle.net/10183/206429
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Archives of endocrinology and metabolism. São Paulo, SP. Vol. 61, n. 6 (2017), p. 614-622
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/206429/2/001110514.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/206429/1/001110514.pdf
bitstream.checksum.fl_str_mv d7447edaa52c00c7ab0058b847b0a458
905f5ec0b9c00f7c4eed7cb5adc694f6
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1815447708918349824